|
Fusion gene ID: 6382 |
FusionGeneSummary for CDC42_ALPL |
Fusion gene summary |
Fusion gene information | Fusion gene name: CDC42_ALPL | Fusion gene ID: 6382 | Hgene | Tgene | Gene symbol | CDC42 | ALPL | Gene ID | 998 | 249 |
Gene name | cell division cycle 42 | alkaline phosphatase, liver/bone/kidney | |
Synonyms | CDC42Hs|G25K|TKS | AP-TNAP|APTNAP|HOPS|TNALP|TNAP|TNSALP | |
Cytomap | 1p36.12 | 1p36.12 | |
Type of gene | protein-coding | protein-coding | |
Description | cell division control protein 42 homologG25K GTP-binding proteinGTP binding protein, 25kDadJ224A6.1.1 (cell division cycle 42 (GTP-binding protein, 25kD))dJ224A6.1.2 (cell division cycle 42 (GTP-binding protein, 25kD))growth-regulating proteinsmall | alkaline phosphatase, tissue-nonspecific isozymealkaline phosphatase liver/bone/kidney isozymeliver/bone/kidney-type alkaline phosphatasetissue non-specific alkaline phosphatasetissue-nonspecific ALP | |
Modification date | 20180526 | 20180522 | |
UniProtAcc | P60953 | P05186 | |
Ensembl transtripts involved in fusion gene | ENST00000400259, ENST00000344548, ENST00000315554, ENST00000498236, ENST00000421089, | ENST00000539907, ENST00000540617, ENST00000374840, ENST00000468526, ENST00000374832, ENST00000425315, ENST00000374830, ENST00000374829, | |
Fusion gene scores | * DoF score | 6 X 5 X 3=90 | 3 X 1 X 3=9 |
# samples | 6 | 3 | |
** MAII score | log2(6/90*10)=-0.584962500721156 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/9*10)=1.73696559416621 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: CDC42 [Title/Abstract] AND ALPL [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | CDC42 | GO:0030036 | actin cytoskeleton organization | 11035016 |
Hgene | CDC42 | GO:0031274 | positive regulation of pseudopodium assembly | 11035016 |
Hgene | CDC42 | GO:0051489 | regulation of filopodium assembly | 14978216 |
Hgene | CDC42 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading | 11807099 |
Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | LD | SKCM | TCGA-DA-A1HW-06A | CDC42 | chr1 | 22379235 | + | ALPL | chr1 | 21880471 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5UTR-intron | ENST00000400259 | ENST00000539907 | CDC42 | chr1 | 22379235 | + | ALPL | chr1 | 21880471 | + |
5UTR-intron | ENST00000400259 | ENST00000540617 | CDC42 | chr1 | 22379235 | + | ALPL | chr1 | 21880471 | + |
5UTR-5UTR | ENST00000400259 | ENST00000374840 | CDC42 | chr1 | 22379235 | + | ALPL | chr1 | 21880471 | + |
5UTR-intron | ENST00000400259 | ENST00000468526 | CDC42 | chr1 | 22379235 | + | ALPL | chr1 | 21880471 | + |
5UTR-5UTR | ENST00000400259 | ENST00000374832 | CDC42 | chr1 | 22379235 | + | ALPL | chr1 | 21880471 | + |
5UTR-intron | ENST00000400259 | ENST00000425315 | CDC42 | chr1 | 22379235 | + | ALPL | chr1 | 21880471 | + |
5UTR-intron | ENST00000400259 | ENST00000374830 | CDC42 | chr1 | 22379235 | + | ALPL | chr1 | 21880471 | + |
5UTR-intron | ENST00000400259 | ENST00000374829 | CDC42 | chr1 | 22379235 | + | ALPL | chr1 | 21880471 | + |
5UTR-intron | ENST00000344548 | ENST00000539907 | CDC42 | chr1 | 22379235 | + | ALPL | chr1 | 21880471 | + |
5UTR-intron | ENST00000344548 | ENST00000540617 | CDC42 | chr1 | 22379235 | + | ALPL | chr1 | 21880471 | + |
5UTR-5UTR | ENST00000344548 | ENST00000374840 | CDC42 | chr1 | 22379235 | + | ALPL | chr1 | 21880471 | + |
5UTR-intron | ENST00000344548 | ENST00000468526 | CDC42 | chr1 | 22379235 | + | ALPL | chr1 | 21880471 | + |
5UTR-5UTR | ENST00000344548 | ENST00000374832 | CDC42 | chr1 | 22379235 | + | ALPL | chr1 | 21880471 | + |
5UTR-intron | ENST00000344548 | ENST00000425315 | CDC42 | chr1 | 22379235 | + | ALPL | chr1 | 21880471 | + |
5UTR-intron | ENST00000344548 | ENST00000374830 | CDC42 | chr1 | 22379235 | + | ALPL | chr1 | 21880471 | + |
5UTR-intron | ENST00000344548 | ENST00000374829 | CDC42 | chr1 | 22379235 | + | ALPL | chr1 | 21880471 | + |
5UTR-intron | ENST00000315554 | ENST00000539907 | CDC42 | chr1 | 22379235 | + | ALPL | chr1 | 21880471 | + |
5UTR-intron | ENST00000315554 | ENST00000540617 | CDC42 | chr1 | 22379235 | + | ALPL | chr1 | 21880471 | + |
5UTR-5UTR | ENST00000315554 | ENST00000374840 | CDC42 | chr1 | 22379235 | + | ALPL | chr1 | 21880471 | + |
5UTR-intron | ENST00000315554 | ENST00000468526 | CDC42 | chr1 | 22379235 | + | ALPL | chr1 | 21880471 | + |
5UTR-5UTR | ENST00000315554 | ENST00000374832 | CDC42 | chr1 | 22379235 | + | ALPL | chr1 | 21880471 | + |
5UTR-intron | ENST00000315554 | ENST00000425315 | CDC42 | chr1 | 22379235 | + | ALPL | chr1 | 21880471 | + |
5UTR-intron | ENST00000315554 | ENST00000374830 | CDC42 | chr1 | 22379235 | + | ALPL | chr1 | 21880471 | + |
5UTR-intron | ENST00000315554 | ENST00000374829 | CDC42 | chr1 | 22379235 | + | ALPL | chr1 | 21880471 | + |
3UTR-intron | ENST00000498236 | ENST00000539907 | CDC42 | chr1 | 22379235 | + | ALPL | chr1 | 21880471 | + |
3UTR-intron | ENST00000498236 | ENST00000540617 | CDC42 | chr1 | 22379235 | + | ALPL | chr1 | 21880471 | + |
3UTR-5UTR | ENST00000498236 | ENST00000374840 | CDC42 | chr1 | 22379235 | + | ALPL | chr1 | 21880471 | + |
3UTR-intron | ENST00000498236 | ENST00000468526 | CDC42 | chr1 | 22379235 | + | ALPL | chr1 | 21880471 | + |
3UTR-5UTR | ENST00000498236 | ENST00000374832 | CDC42 | chr1 | 22379235 | + | ALPL | chr1 | 21880471 | + |
3UTR-intron | ENST00000498236 | ENST00000425315 | CDC42 | chr1 | 22379235 | + | ALPL | chr1 | 21880471 | + |
3UTR-intron | ENST00000498236 | ENST00000374830 | CDC42 | chr1 | 22379235 | + | ALPL | chr1 | 21880471 | + |
3UTR-intron | ENST00000498236 | ENST00000374829 | CDC42 | chr1 | 22379235 | + | ALPL | chr1 | 21880471 | + |
5UTR-intron | ENST00000421089 | ENST00000539907 | CDC42 | chr1 | 22379235 | + | ALPL | chr1 | 21880471 | + |
5UTR-intron | ENST00000421089 | ENST00000540617 | CDC42 | chr1 | 22379235 | + | ALPL | chr1 | 21880471 | + |
5UTR-5UTR | ENST00000421089 | ENST00000374840 | CDC42 | chr1 | 22379235 | + | ALPL | chr1 | 21880471 | + |
5UTR-intron | ENST00000421089 | ENST00000468526 | CDC42 | chr1 | 22379235 | + | ALPL | chr1 | 21880471 | + |
5UTR-5UTR | ENST00000421089 | ENST00000374832 | CDC42 | chr1 | 22379235 | + | ALPL | chr1 | 21880471 | + |
5UTR-intron | ENST00000421089 | ENST00000425315 | CDC42 | chr1 | 22379235 | + | ALPL | chr1 | 21880471 | + |
5UTR-intron | ENST00000421089 | ENST00000374830 | CDC42 | chr1 | 22379235 | + | ALPL | chr1 | 21880471 | + |
5UTR-intron | ENST00000421089 | ENST00000374829 | CDC42 | chr1 | 22379235 | + | ALPL | chr1 | 21880471 | + |
Top |
FusionProtFeatures for CDC42_ALPL |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
CDC42 | ALPL |
Plasma membrane-associated small GTPase which cyclesbetween an active GTP-bound and an inactive GDP-bound state. Inactive state binds to a variety of effector proteins to regulatecellular responses. Involved in epithelial cell polarizationprocesses. Regulates the bipolar attachment of spindlemicrotubules to kinetochores before chromosome congression inmetaphase. Plays a role in the extension and maintenance of theformation of thin, actin-rich surface projections calledfilopodia. Mediates CDC42-dependent cell migration. Required forDOCK10-mediated spine formation in Purkinje cells and hippocampalneurons. Facilitates filopodia formation upon DOCK11-activation(By similarity). Also plays a role in phagocytosis throughorganization of the F-actin cytoskeleton associated with formingphagocytic cups. {ECO:0000250|UniProtKB:P60766,ECO:0000269|PubMed:14978216, ECO:0000269|PubMed:15642749,ECO:0000269|PubMed:17038317, ECO:0000269|PubMed:26465210}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for CDC42_ALPL |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for CDC42_ALPL |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
CDC42 | DOCK8, TRIP10, CDC42EP1, ARHGDIA, PAK4, FNBP1L, CDC42BPG, ARHGAP27, DEF6, MCF2L, ARHGAP32, PAK1, KAT5, C14orf1, PDE6D, UBR1, LRIF1, TP53, EEF1G, UNC119, BNIP2, CDC42EP3, BAIAP2, PAK2, VAV1, MAP3K10, ARHGAP1, MAP3K11, CDC42SE1, CDC42SE2, CDC42, CSPG4, IQGAP2, NCF2, MAP3K4, GDI1, TNK2, PAK7, ERRFI1, PAK6, ARHGAP26, ARHGAP10, ARHGAP17, ARHGAP44, IQGAP1, PARD6A, PARD6B, OPHN1, CLIP1, WAS, WASL, MCF2, DOCK9, CDC42EP5, CDC42EP2, PLEKHG2, ARHGDIG, PARD6G, FGD1, ARHGEF25, PLD1, ITSN1, BCR, ARRB1, ARRB2, CSN2, DIAPH2, COX1, MYO6, MYO9A, PAK3, RAP1GDS1, RPL22, S100A9, ST13, UBC, VRK2, ZNF175, CDC42BPA, MCM3AP, HERC2, RPL23, CDC42BPB, ARHGEF11, SYNE1, CDC42EP4, FMNL2, SH3D19, KIAA2026, MUC12, CBL, ARHGEF7, TNF, CBLL1, CDH1, MARK4, A2M, AHSG, APOH, CPN1, ETFA, CFHR4, LGALS1, ZNF234, GRB2, ABCA1, ELAVL1, USP6, BCAR1, SH3RF3, LRRK2, ARHGEF6, FGD3, TGFBR1, TGFBR2, RAP1A, ZNF420, DIAPH3, WIPF1, RIOK3, SSX2IP, NEK6, EPRS, LARS, RUVBL1, TCEB2, BIRC2, TRAF2, ERCC3, UNK, AHNAK, ATP6V1H, HNRNPA1, RAP1B, DUT, FARSA, NOTCH2, RAB11B, RAB14, RAB1A, RAB1B, STMN1, UQCRC2, VAPA, ARHGAP35, IFI16, DBN1, GOLT1B, LIMA1, GTSE1, FANCD2, KIFC3, MECP2, MSH3, MYH10, NDUFV3, PRDX1, RAD51, STX3, SF1, EIF2B3, SEC24C, GOLGA5, ARPC5, CEPT1, PRDX3, FKBP9, SCMH1, ZC3H4, PNISR, GOLIM4, ACAD9, ASTE1, POLR1D, NT5C3A, ZAK, SLC38A2, DNAJC10, MIEF1, EPB41L4B, RASIP1, RABL6, BBX, KIF17, ZSWIM5, WNK1, IQGAP3, MAPK9, MAPK8, CASP3, RCC2, MCM2, AGAP2, AGAP1, DLD, SOD1 | ALPL | FBXO6, EEF1A1, SRPK2, ALOX5, SPCS2, SEC11C |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for CDC42_ALPL |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Tgene | ALPL | P05186 | DB09338 | Mersalyl | Alkaline phosphatase, tissue-nonspecific isozyme | small molecule | approved |
Top |
RelatedDiseases for CDC42_ALPL |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | CDC42 | C0036341 | Schizophrenia | 4 | PSYGENET |
Hgene | CDC42 | C0001624 | Adrenal Gland Neoplasms | 1 | CTD_human |
Hgene | CDC42 | C0019693 | HIV Infections | 1 | CTD_human |
Hgene | CDC42 | C0024667 | Animal Mammary Neoplasms | 1 | CTD_human |
Hgene | CDC42 | C0024668 | Mammary Neoplasms, Experimental | 1 | CTD_human |
Hgene | CDC42 | C0027540 | Necrosis | 1 | CTD_human |
Hgene | CDC42 | C4225222 | TAKENOUCHI-KOSAKI SYNDROME | 1 | UNIPROT |
Tgene | ALPL | C0268413 | Adult hypophosphatasia (disorder) | 27 | CTD_human;ORPHANET;UNIPROT |
Tgene | ALPL | C0220743 | Childhood hypophosphatasia (disorder) | 8 | CTD_human;ORPHANET;UNIPROT |
Tgene | ALPL | C0268412 | Infantile hypophosphatasia | 5 | CTD_human;HPO;ORPHANET;UNIPROT |
Tgene | ALPL | C0002382 | Alveolar Bone Loss | 1 | CTD_human |
Tgene | ALPL | C0006663 | Calcinosis | 1 | CTD_human |
Tgene | ALPL | C0018843 | Heat Stroke | 1 | CTD_human |
Tgene | ALPL | C0020503 | Hyperparathyroidism, Secondary | 1 | CTD_human |
Tgene | ALPL | C0023895 | Liver diseases | 1 | CTD_human |
Tgene | ALPL | C0036572 | Seizures | 1 | CTD_human;HPO |